2017-07-01
Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice
Publication
Publication
Journal of Rheumatology , Volume 44 - Issue 7 p. 965- 967
Additional Metadata | |
---|---|
doi.org/10.3899/jrheum.170334, hdl.handle.net/1765/100850 | |
Journal of Rheumatology | |
Organisation | Rheumatology |
Kuijper, M., Buisman, L., Hazes, M., & Weel, A. (2017). Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice. Journal of Rheumatology, 44(7), 965–967. doi:10.3899/jrheum.170334 |